Related references
Note: Only part of the references are listed.The AGE-RAGE Axis: Implications for Age-Associated Arterial Diseases
Laura M. Senatus et al.
FRONTIERS IN GENETICS (2017)
The multiple faces of RAGE - opportunities for therapeutic intervention in aging and chronic disease
Ravichandran Ramasamy et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2016)
The clinical significance of circulating soluble RAGE in patients with severe sepsis
Hisatake Matsumoto et al.
Journal of Trauma and Acute Care Surgery (2015)
Soluble RAGEs - Prospects for treating & tracking metabolic and inflammatory disease
Ann Marie Schmidt
VASCULAR PHARMACOLOGY (2015)
The clinical significance of circulating soluble RAGE in patients with severe sepsis
Hisatake Matsumoto et al.
Journal of Trauma and Acute Care Surgery (2015)
Relationship of Advanced Glycation End Products With Cardiovascular Disease in Menopausal Women
Magdalena Pertynska-Marczewska et al.
REPRODUCTIVE SCIENCES (2015)
Two Soluble Isoforms of Receptors for Advanced Glycation End Products (RAGE) in Carotid Atherosclerosis: The Difference of Soluble and Endogenous Secretory RAGE
Saori Moriya et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2014)
Radical Roles for RAGE in the Pathogenesis of Oxidative Stress in Cardiovascular Diseases and Beyond
Gurdip Daffu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Receptor for Advanced Glycation End Products and Its Involvement in Inflammatory Diseases
Yaw Kuang Chuah et al.
INTERNATIONAL JOURNAL OF INFLAMMATION (2013)
The relationship between receptor for advanced glycation end products expression and the severity of periodontal disease in the gingiva of diabetic and non diabetic periodontitis patients
Marwa Magdy Abbass et al.
ARCHIVES OF ORAL BIOLOGY (2012)
The diverse ligand repertoire of the receptor for advanced glycation endproducts and pathways to the complications of diabetes
Ravichandran Ramasamy et al.
VASCULAR PHARMACOLOGY (2012)
AGE restriction in diabetes mellitus: a paradigm shift
Helen Vlassara et al.
NATURE REVIEWS ENDOCRINOLOGY (2011)
Diabetes mellitus and periodontitis: a tale of two common interrelated diseases
Evanthia Lalla et al.
NATURE REVIEWS ENDOCRINOLOGY (2011)
Role of receptors of advanced glycation end-products (RAGE) in type 2 diabetic and non-diabetic individuals with chronic periodontal disease: an immunohistochemical study
Karattuparambath Rajeev et al.
JOURNAL OF INVESTIGATIVE AND CLINICAL DENTISTRY (2011)
Soluble RAGE: Therapy and biomarker in unraveling the RAGE axis in chronic disease and aging
Shi Fang Yan et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Circulating soluble receptor for advanced glycation end products is inversely associated with body mass index and waist/hip ratio in the general population
Giuseppe Danilo Norata et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2009)
Soluble receptor for advanced glycation end products: a new biomarker in diagnosis and prognosis of chronic inflammatory diseases
Helene Maillard-Lefebvre et al.
RHEUMATOLOGY (2009)
The decrease of soluble RAGE levels in rheumatoid arthritis patients following hormone replacement therapy is associated with increased bone mineral density and diminished bone/cartilage turnover: a randomized controlled trial
Rille Pullerits et al.
RHEUMATOLOGY (2009)
Advanced glycation end product homeostasis - Exogenous oxidants and innate defenses
Helen Vlassara et al.
MAILLARD REACTION: RECENT ADVANCES IN FOOD AND BIOMEDICAL SCIENCES (2008)
Endogenous secretory RAGE but not soluble RAGE is associated with carotid atherosclerosis in type 1 diabetes patients
Naoto Katakami et al.
DIABETES & VASCULAR DISEASE RESEARCH (2008)
Identification, classification, and expression of RAGE gene splice variants
Barry I. Hudson et al.
FASEB JOURNAL (2008)
A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10)
Angela Raucci et al.
FASEB JOURNAL (2008)
Receptor for Advanced Glycation End Products Is Subjected to Protein Ectodomain Shedding by Metalloproteinases
Ling Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Soluble RAGE but not endogenous secretory RAGE is associated with albuminuria in patients with type 2 diabetes
Per M. Humpert et al.
CARDIOVASCULAR DIABETOLOGY (2007)
Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia
E Emanuele et al.
ARCHIVES OF NEUROLOGY (2005)
Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men
C Falcone et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Expression of the receptor of advanced glycation end products in gingival tissues of type 2 diabetes patients with chronic periodontal disease: a study utilizing immunohistochemistry and RT-PCR
J Katz et al.
JOURNAL OF CLINICAL PERIODONTOLOGY (2005)
Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control
R Pullerits et al.
ARTHRITIS RESEARCH & THERAPY (2005)
RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy
TM Wendt et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury
H Yonekura et al.
BIOCHEMICAL JOURNAL (2003)
Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE
MP Wautier et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2001)
Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases
A Taguchi et al.
NATURE (2000)
Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice
E Lalla et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Share Paper
